Long-term chemotherapy of HIV-associated Kaposi's sarcoma with liposomal doxorubicin

Author： Hengge U.R. Esser S. Rudel H.-P. Goos M.

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.37, Iss.7, 2001-05, pp. : 878-883

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-effectiveness Analysis of Pegylated-liposomal Doxorubicin and Liposomal Daunorubicin Treatments in Patients with Kaposi's Sarcoma

By Hjortsberg Catharina Persson Ulf Lidbrink Elisabet Bennett Charles

Acta Oncologica, Vol. 38, Iss. 8, 1999-12 ,pp. : 1063-1067

Informa Healthcare

Access to resources Recommend Favorite

Spotlight on Polyethylene Glycol-Liposomal Doxorubicin in Solid and Hematological Malignancies and AIDS-Related Kaposi's Sarcoma

By Sharpe M. Easthope S.E. Keating G.M. Lamb H.M.

American Journal of Cancer, Vol. 2, Iss. 1, 2003-01 ,pp. : 67-72

Adis International

Access to resources Recommend Favorite

Liposomal Pegylated Doxorubicin versus Low-Dose Recombinant Interferon Alfa-2a in the Treatment of Advanced Classic Kaposi's Sarcoma; Retrospective Analysis of Three German Centers

By Kreuter Alexander Rasokat Heinrich Klouche Mariam Esser Stefan Bader Armin Gambichler Thilo Altmeyer Peter Brockmeyer Norbert

Cancer Investigation, Vol. 23, Iss. 8, 2005-11 ,pp. : 653-659

Informa Healthcare

Access to resources Recommend Favorite

Seroepidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV)

By Chatlynne L.G. Ablashi D.V.

Seminars in Cancer Biology, Vol. 9, Iss. 3, 1999-06 ,pp. : 175-185

Academic Press

Access to resources Recommend Favorite

Gemcitabine in bone sarcoma resistant to doxorubicin-based chemotherapy

By Merimsky Ofer Meller Isaac Kollender Yehuda Issakov Josephine Flusser Gideon Inbar Moshe

Sarcoma, Vol. 4, Iss. 1-2, 2000-03 ,pp. : 7-10

Informa Healthcare

Access to resources Recommend Favorite